Carbosilane dendrons with fatty acids at the core as a new potential microbicide against HSV-2/HIV-1 co-infection

被引:18
|
作者
Guerrero-Beltran, C. [1 ,2 ,3 ,4 ]
Cena-Diez, R. [1 ,2 ,3 ]
Sepulveda-Crespo, D. [1 ,2 ,3 ]
De la Mata, J. [5 ,6 ]
Gomez, R. [5 ,6 ]
Leal, M. [7 ]
Munoz-Fernandez, M. A. [1 ,2 ,3 ,6 ]
Jimenez, J. L. [2 ,3 ,4 ,6 ]
机构
[1] Hosp Gen Univ Gregorio Maranon, Lab Inmunobiol Mol, Immunol Sect, Madrid, Spain
[2] Spanish HIV HGM BioBank, Madrid, Spain
[3] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain
[4] Hosp Gen Univ Gregorio Maranon, Plataforma Lab, Inst Invest Sanit Gregorio Maranon, Madrid, Spain
[5] Univ Alcala, Dept Quim Organ & Quim Inorgan, Campus Univ, Madrid, Spain
[6] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain
[7] Hosp Univ Virgen Rocio, Inst Biomed Sevilla IBiS, Seville, Spain
关键词
HERPES-SIMPLEX-VIRUS; HIV-1; TRANSMISSION; DENDRIMER; EFFICACY; COMBINATION; PREVENTION; INHIBITORS; MECHANISM; INFECTION; RECEPTOR;
D O I
10.1039/c7nr05859d
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Herpes simplex virus type 2 (HSV-2) and human immunodeficiency virus type 1 (HIV-1) represent the two most frequent sexually transmitted infections (STI) worldwide. Epidemiological studies suggest that HSV-2 increases the risk of HIV-1 acquisition approximately 3-fold mainly due to the clinical and immunological manifestations. In the absence of vaccines against both STI, the development of new preventive strategies has become essential for further studies. We performed the screening of six novel polyanionic carbosilane dendrons to elucidate their potential activity against HSV-2/HIV-1 co-infection and their mechanism of action. These new nanoparticles are carbosilane branched dendrons from first to third generation, with palmitic or hexanoic fatty acids as the core and capped with sulfonate groups, named G1(d)-STE2Hx, G2(d)-STE4Hx, G3(d)-STE8Hx, G1(d)-STE2Pm, G2(d)-STE4Pm and G3(d)-STE8Pm. G3(d)-STE8Hx and G3(d)-STE8Pm carbosilane branched dendrons showed high viability. These dendrons also showed a great broadspectrum antiviral activity, as well as a suitable efficacy against HIV-1 even if the mucosal disruption occurs as a consequence of HSV-2 infection. Our results exert high inhibition against HSV-2 and HIV-1 by blocking the entry of both viruses with the median effective concentration EC50 values in the nanomolar range. Additionally, G3(d)-STE8Hx and G3(d)-STE8Pm retained their anti-HSV-2/HIV-1 activity at different pH values. G3(d)-STE8Hx and G3(d)-STE8Pm dendrons may be potential candidates as dual-acting microbicides against HSV-2/HIV-1 co-infection.
引用
收藏
页码:17263 / 17273
页数:11
相关论文
共 50 条
  • [41] Deciphering long-term immune effects of HIV-1/SARS-CoV-2 co-infection: a longitudinal study
    Vazquez-Alejo, Elena
    de la Sierra Espinar-buitrago, Maria
    Magro-Lopez, Esmeralda
    Tarancon-Diez, Laura
    Diez, Cristina
    Bernardino, Jose Ignacio
    Rull, Anna
    de los Santos, Ignacio
    Alonso, Roberto
    Zamora, Angielys
    Jimenez, Jose Luis
    Munoz-Fernandez, Ma Angeles
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2025, 214 (01)
  • [42] Human mpox co-infection with advanced HIV-1 and XDR-TB in a MSM patient previously vaccinated against smallpox: A case report
    Fang Yuan
    Wang Fuchun
    Jiang Taiyi
    Duan Junyi
    Huang Tao
    Liu Hao
    Jia Lin
    Jia Han
    Yan Benyong
    Zhang Mei
    Wang Wen
    Guo Caiping
    Liu Lifeng
    Zhang Yuening
    Zhang Tong
    生物安全与健康(英文), 2024, 06 (03)
  • [43] Human mpox co-infection with advanced HIV-1 and XDR-TB in a MSM patient previously vaccinated against smallpox: A case report
    Fang, Yuan
    Wang, Fuchun
    Jiang, Taiyi
    Duan, Junyi
    Huang, Tao
    Liu, Hao
    Jia, Lin
    Jia, Han
    Yan, Benyong
    Zhang, Mei
    Wang, Wen
    Guo, Caiping
    Liu, Lifeng
    Zhang, Yuening
    Zhang, Tong
    BIOSAFETY AND HEALTH, 2024, 6 (03) : 186 - 190
  • [44] Deciphering the epidemic synergy of herpes simplex virus type 2 (HSV-2) on human immunodeficiency virus type 1 (HIV-1) infection among women in sub-Saharan Africa
    Ghebremichael M.
    Habtzgi D.
    Paintsil E.
    BMC Research Notes, 5 (1)
  • [45] HIV-1+/HSV-2+ Co-infection Is Associated with Persistence of CD14+ and DC-SIGN+ Antigen Presenting Cells at the Mucosa Independent of HSV Recurrences
    Preza, Gloria C.
    Keller, Marla J.
    Ochoa, Maria T.
    Herold, Betsy
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 : A281 - A281
  • [46] CO-INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS-TYPE-1 (HIV-1) AND CYTOMEGALO-VIRUS IN 2 INTRAVENOUS DRUG-USERS
    BONETTI, A
    WEBER, R
    VOGT, MW
    WUNDERLI, W
    SIEGENTHALER, W
    LUTHY, R
    ANNALS OF INTERNAL MEDICINE, 1989, 111 (04) : 293 - 296
  • [47] Double-edged effect of Vγ/Vδ2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infection
    Biswas, P
    Ferrarini, M
    Mantelli, B
    Fortis, C
    Poli, G
    Lazzarin, A
    Manfredi, AA
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (01) : 252 - 263
  • [48] In Vitro Exposure to PC-1005 and Cervicovaginal Lavage Fluid from Women Vaginally Administered PC-1005 Inhibits HIV-1 and HSV-2 Infection in Human Cervical Mucosa
    Villegas, Guillermo
    Calenda, Giulia
    Zhang, Shimin
    Mizenina, Olga
    Kleinbeck, Kyle
    Cooney, Michael L.
    Hoesley, Craig J.
    Creasy, George W.
    Friedland, Barbara
    Fernandez-Romero, Jose A.
    Zydowsky, Thomas M.
    Teleshova, Natalia
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (09) : 5459 - 5466
  • [49] Herpes simplex virus-2 infections in pregnant women from Durban, South Africa: prevalence, risk factors and co-infection with HIV-1
    Abbai, Nathlee S.
    Govender, Shanthie
    Nyirenda, Makandwe
    SOUTHERN AFRICAN JOURNAL OF INFECTIOUS DISEASES, 2018, 33 (05)
  • [50] Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection
    Brunetta, Enrico
    Fogli, Manuela
    Varchetta, Stefania
    Bozzo, Luisa
    Hudspeth, Kelly L.
    Marcenaro, Emanuela
    Moretta, Alessandro
    Mavilio, Domenico
    AIDS, 2010, 24 (01) : 27 - 34